Michael Method

Michael Method is an experienced pharmaceutical professional currently serving as Senior Vice President at Karyopharm Therapeutics Inc. since May 2024. Prior to this role, Michael held the position of Executive Medical Director at ImmunoGen, Inc. from April 2021 to April 2024. Michael also worked at Eli Lilly and Company from October 2018 to April 2021, where the roles included Senior Medical Advisor & Global Lead for Adjuvant Breast. Michael is recognized for contributions to team dynamics and a strong commitment to professional journeys in the medical field.